BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8328094)

  • 1. [Malignant parotid tumors. Therapeutic results and prognosis in 110 consecutive patients].
    Pedersen DE; Overgaard J; Søgaard H; Elbrønd O; Overgaard M
    Ugeskr Laeger; 1993 Jul; 155(29):2255-9. PubMed ID: 8328094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis.
    Pedersen D; Overgaard J; Søgaard H; Elbrønd O; Overgaard M
    Laryngoscope; 1992 Sep; 102(9):1064-9. PubMed ID: 1518354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
    Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
    Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of epithelial parotid tumours.
    Obaid MA; Yusuf A
    J Coll Physicians Surg Pak; 2004 Jul; 14(7):394-9. PubMed ID: 15279739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of malignant parotid tumors. Results from the county of Copenhagen].
    Charabi S; Christensen NR; Charabi BW; Nielsen PT; Balle VH; Thomsen JC; Tos M
    Ugeskr Laeger; 1999 Nov; 161(45):6191-4. PubMed ID: 10603756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland.
    Carrillo JF; Vázquez R; Ramírez-Ortega MC; Cano A; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Cancer; 2007 May; 109(10):2043-51. PubMed ID: 17410532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid tumors: a 10-year experience.
    Lin CC; Tsai MH; Huang CC; Hua CH; Tseng HC; Huang ST
    Am J Otolaryngol; 2008; 29(2):94-100. PubMed ID: 18314019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenoid cystic carcinoma of the head and neck: a review of 30 cases].
    Raux-Rakotomalala F; Houliat T; Martel J; Stoll D; Bébéar JP; Darrouzet V
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):235-41. PubMed ID: 15038566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of locally advanced, high-grade, malignant tumors of major salivary glands.
    Reddy SP; Marks JE
    Laryngoscope; 1988 Apr; 98(4):450-4. PubMed ID: 2832670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant tumors of the nasal cavity and paranasal sinuses.
    Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
    Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
    Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
    J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid cancer: treatment and results.
    Roberson DW; Chu FW; Yarington CT
    Ear Nose Throat J; 1993 Dec; 72(12):787-93. PubMed ID: 8313862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.